 |
| | | | | | |
|---|
 | 2014 |
| |
 | 2015 |
| |
| 01 |
| |
| 02 |
| |
| 03 |
| |
| 04 |
| |
| | 04/30/2015 | 09:00 AM | | Paul T. Anastas Awarded Emanuel Merck Lectureship 2015 |   | |
| | 04/27/2015 | 10:23 AM | | EMD Millipore Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs | | |
| | 04/25/2015 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Wins German Innovation Award with Liquid Crystals | | |
| | 04/20/2015 | 02:00 PM | | Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer | | |
| | 04/17/2015 | 03:05 PM | | Annual General Meeting Approves Dividend Increase | | |
| | 04/17/2015 | 10:20 AM | | Merck KGaA, Darmstadt, Germany, Proposes Dividend Increase to Shareholders After a Year of Key Strategic Moves – Foundation Set for Further Organic Growth | | |
| | 04/15/2015 | 10:00 AM | | “Living Innovation”: Merck KGaA, Darmstadt, Germany, at the European Coatings Show 2015 | | |
| | 04/13/2015 | 03:15 PM | | Merck KGaA, Darmstadt, Germany, Appoints Udit Batra to Head Combined Life Science Business Following Pending Sigma-Aldrich Acquisition | | |
| | 04/07/2015 | 02:00 PM | | Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib) | | |
| 05 |
| |
| 06 |
| |
| 07 |
| |
| 08 |
| |
| 09 |
| |
| 10 |
| |
| 11 |
| |
| 12 |
| |
| 2016 |
| |
| 2017 |
| |
| 2018 |
| |
|